• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Adenylate cyclase activation and competitive binding with renal tissue using synthetic eel calcitonin analog and its fragments.

作者信息

Yamamoto I, Morita R, Fukunaga M, Dokoh S, Shigeno C, Torizuka K, Noda T

出版信息

Endocrinology. 1981 Feb;108(2):698-702. doi: 10.1210/endo-108-2-698.

DOI:10.1210/endo-108-2-698
PMID:7449744
Abstract

The structure-function relationship of calcitonin (CT) was investigated using a synthetic eel CT (E-CT) analog and its fragments. Adenylate cyclase activation and competitive binding to rat renal receptors were used as parameters of function. [Asu1,7]E-CT analog, synthesized by replacing the S-S bond of Cys1-Cys7 in the natural hormone with ethylene linkage of 1-amino suberic acid (Asu), and E-CT fragment 11-32 had about 1/5th and 1/50th the potencies of synthetic E-CT, respectively, in both adenylate cyclase activation and competitive inhibition of 125I-labeled [Asu1,7]iodo-E-CT binding on rat renal plasma membranes. The minimal chain length required to activate adenylate cyclase in rat renal plasma membranes was between 12-18 amino acids, and the minimal chain length required to affect the CT receptor binding was between 6-12 amino acids, near the C-terminus. Fragments, including the C-terminus, show a disproportionate and potent inhibition of the binding compared with the potency required for adenylate cyclase activation. Thus, the amino acid sequence near the C-terminus probably plays an important role in the binding of CT to the receptor. (Endocrinology 108: 698, 1981.)

摘要

相似文献

1
Adenylate cyclase activation and competitive binding with renal tissue using synthetic eel calcitonin analog and its fragments.
Endocrinology. 1981 Feb;108(2):698-702. doi: 10.1210/endo-108-2-698.
2
Divergent structural requirements exist for calcitonin receptor binding specificity and adenylate cyclase activation.降钙素受体结合特异性和腺苷酸环化酶激活存在不同的结构要求。
Mol Pharmacol. 1995 Apr;47(4):798-809.
3
Renal receptors for calcitonin: coordinate occurrence with calcitonin-activated adenylate cyclase.降钙素的肾受体:与降钙素激活的腺苷酸环化酶协同出现。
Endocrinology. 1975 Aug;97(2):448-53. doi: 10.1210/endo-97-2-448.
4
Determinants for calcitonin analog interaction with the calcitonin receptor N-terminus and transmembrane-loop regions.降钙素类似物与降钙素受体N端和跨膜环区域相互作用的决定因素。
Endocrinology. 1996 Nov;137(11):4752-6. doi: 10.1210/endo.137.11.8895343.
5
Control of cyclic adenosine 3',5'-monophosphate production in osteoclasts: calcitonin-induced persistent activation and homologous desensitization of adenylate cyclase.破骨细胞中环磷酸腺苷生成的调控:降钙素诱导的腺苷酸环化酶持续激活及同源脱敏
Endocrinology. 1987 May;120(5):1902-8. doi: 10.1210/endo-120-5-1902.
6
Photoaffinity labeling of rat calcitonin gene-related peptide receptors and adenylate cyclase activation: identification of receptor subtypes.大鼠降钙素基因相关肽受体的光亲和标记与腺苷酸环化酶激活:受体亚型的鉴定
Endocrinology. 1993 Feb;132(2):744-50. doi: 10.1210/endo.132.2.8381072.
7
[Asu(1,7)E-CT, an analog of eel calcitonin. A comparative study in man with reference to other synthetic calcitonins].[鳗降钙素类似物Asu(1,7)E-CT。与其他合成降钙素相比的人体对照研究]
Minerva Med. 1983 Apr 28;74(18):993-1010.
8
Examination of interspecies differences in renal and skeletal receptor binding and adenylate cyclase stimulation with human calcitonin.用人降钙素检测肾脏和骨骼中受体结合及腺苷酸环化酶刺激的种间差异。
Endocrinology. 1980 Feb;106(2):510-8. doi: 10.1210/endo-106-2-510.
9
Homologous regulation of the rat C1a calcitonin receptor (CTR) in nonosteoclastic cells is independent of CTR messenger ribonucleic acid changes and cyclic adenosine 3',5'-monophosphate-dependent protein kinase activation.大鼠C1a降钙素受体(CTR)在非破骨细胞中的同源性调节独立于CTR信使核糖核酸变化及环磷酸腺苷依赖性蛋白激酶激活。
Endocrinology. 1996 Nov;137(11):4576-85. doi: 10.1210/endo.137.11.8895320.
10
Rat parathyroid hormone-(1-34) fragment: renal adenylate cyclase activity and receptor binding properties in vitro.大鼠甲状旁腺激素-(1-34)片段:体外肾腺苷酸环化酶活性及受体结合特性
Endocrinology. 1985 Sep;117(3):1230-4. doi: 10.1210/endo-117-3-1230.

引用本文的文献

1
Accelerators of osteogenesis by recombinant human bone morphogenetic protein-2.重组人骨形态发生蛋白-2对成骨的促进作用
Drug Target Insights. 2007;2:55-60. Epub 2007 Feb 21.
2
Alendronate is more effective than elcatonin in improving pain and quality of life in postmenopausal women with osteoporosis.阿仑膦酸钠比依降钙素更能有效改善绝经后骨质疏松症妇女的疼痛和生活质量。
Osteoporos Int. 2011 Oct;22(10):2735-42. doi: 10.1007/s00198-010-1495-8. Epub 2010 Nov 23.
3
Effects of short-term combined treatment with alendronate and elcatonin on bone mineral density and bone turnover in postmenopausal women with osteoporosis.
阿仑膦酸钠与依降钙素短期联合治疗对绝经后骨质疏松症患者骨密度和骨转换的影响。
Ther Clin Risk Manag. 2009 Jun;5(3):499-505. doi: 10.2147/tcrm.s5982. Epub 2009 Jul 12.
4
Calcitonin: regional distribution of the hormone and its binding sites in the human brain and pituitary.降钙素:该激素及其结合位点在人脑和垂体中的区域分布。
Proc Natl Acad Sci U S A. 1981 Dec;78(12):7801-5. doi: 10.1073/pnas.78.12.7801.
5
Relationships among several different non-homologous polypeptide hormones.
Mol Cell Biochem. 1983;57(1):41-7. doi: 10.1007/BF00223523.
6
Effect of human calcitonin (hCT) on glucose- and arginine-stimulated insulin secretion.人降钙素(hCT)对葡萄糖和精氨酸刺激的胰岛素分泌的影响。
Acta Diabetol Lat. 1986 Jan-Mar;23(1):13-22. doi: 10.1007/BF02581349.